The Chinese MOFCOM conditionnaly clears a merger in the vascular closure devices market (Abbott Laboratories / St Jude Medical)

On 30 December 2016, Abbott Laboratories’s acquisition of St Jude Medical was conditionally approved by the MOFCOM. On 4 July 2016, Abbott Laboratories submitted its notification to the MOFCOM, which was accepted as complete on 6 September 2016. The authority’s review entered phase 2 on 6 October 2016. Competition assessment The MOFCOM determined that the proposed acquisition would eliminate or restrict competition in the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Hogan Lovells (Beijing)
  • University of Melbourne
  • China Competition Bulletin (Beijing)
  • University of Melbourne

Quotation

Adrian Emch, Allan Fels, Xiaoye Wang, Wendy Ng, The Chinese MOFCOM conditionnaly clears a merger in the vascular closure devices market (Abbott Laboratories / St Jude Medical), 30 December 2016, e-Competitions Bulletin December 2016, Art. N° 88641

Visites 49

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues